Risk of hepatic steatosis with the preoperative treatment of pancreatic cancer and the short-term postoperative outcomes.
Kazuki KobayashiYoji KishiTakazumi TsunenariNaoto YonamineYasuhiro TakihataAkiko NakazawaMikiya TakaoTakahiro EinamaHironori TsujimotoHideki UenoPublished in: Surgery today (2024)
Preoperative chemotherapy, a history of cholangitis, the presence of PEI, and ≥ 3 months' duration of biliary drainage were risk factors for the development of HS before surgery for pancreatic cancer. However, preoperative HS did not affect the short-term postoperative outcomes.